$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
How to buy Novartis’ new lung cancer drug capmatinib?
2025-10-19 11:44:20
Check Details
Where can I buy the Novartis MET inhibitor capmatinib?
2025-10-19 11:44:20
Check Details
The FDA has approved German Merck’s Tepotinib Hydrochloride Tablets for the treatment of advanced lung cancer
2025-10-19 11:44:20
Check Details
Is the domestic c-MET inhibitor Tepotinib Hydrochloride Tablets from German Merck on the market
2025-10-19 11:44:20
Check Details
Is Tepotinib Hydrochloride Tablets from Merck of Germany useful for brain metastasis
2025-10-19 11:44:20
Check Details
Tepotinib Hydrochloride Tablets from Merck of Germany opens up a new field of targeted treatment for lung cancer
2025-10-19 11:44:20
Check Details
Clinical trial of Tepotinib Hydrochloride Tablets from Merck in Germany
2025-10-19 11:44:20
Check Details
Is Tepotinib Hydrochloride Tablets developed by Merck of Germany
2025-10-19 11:44:20
Check Details
Is Tepotinib Hydrochloride Tablets from Merck in Germany launched on the market
2025-10-19 11:44:20
Check Details
Is Tepotinib Hydrochloride Tablets from Merck Germany an oral MET kinase inhibitor?
2025-10-19 11:44:20
Check Details
The effect of German Merck’s Tipotinib Hydrochloride Tablets in the treatment of non-small cell lung cancer
2025-10-19 11:44:20
Check Details
Study results support the use of larotrectinib in the treatment of NTRK+ lung cancer
2025-10-19 11:44:20
Check Details
1
2
...
3811
3812
3813
3814
3815
3816
3817
...
4152
4153
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
2
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
3
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
4
Cemiplimab (Libtayo) Drug Information
5
Mirvetuximab Soravtansine (Elahere): FRα-Targeted ADC for Platinum-Resistant Ovarian Cancer
6
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
7
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
8
A Revolutionary Targeted Therapy for Hematological Malignancies
9
A New Option for Advanced Renal Cell Carcinoma Treatment
10
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
11
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
12
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide